Back

Development of a risk score for predicting 30-day mortality in Brazilian heart valve surgery patients

1 September 2025 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Multi-valve disease Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Daniella Cian Nazzetta

Heart Institute of the University of Sao Paulo (InCor), Sao Paulo (Brazil)

7 More presentations in this session

Presentation thumbnail
Aorto-mitral angle as a geometric predictor of prosthetic mitral valve deterioration: insights from a retrospective case-control study
Doctor N. Changklungkul (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Aortic valve replacement in asymptomatic individuals with severe aortic stenosis and left ventricular hypertrophy
Associate Professor J. Wasfy (Boston, US)
Abstract Slides Video
Presentation thumbnail
Comparison of outcomes between TAVI and SAVR in patients with bicuspid aortic valve stenosis
Doctor K. Faierstein (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Early aortic valve replacement in asymptomatic severe aortic stenosis: a systematic review and meta-analysis of randomized controlled trials
Doctor J. Giorgi (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Sex-based differences in incidence and mortality of repeat mitral valve surgery for mitral regurgitation: a nationwide cohort study
Miss A. Koeber (Copenhagen, DK)
Abstract Slides Video

Access the full session

Session thumbnail
Multi-valve disease

The Event

Event poster

ESC Congress 2025

1 September 2025 10:15 CET
You may be interested in
thumbnail
Congress Presentation
A novel echocardiographic risk score for mortality in primary mitral regurgitation surgery
thumbnail
Congress Presentation
Comparison of mortality scores performance in transcatheter aortic valve replacement: suiting up to percutaneous intervention.
thumbnail
Congress Presentation
External validation of the EuroSCORE II and the STSPROM for patients undergoing isolated coronary artery bypass grafting in a developing country

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources